Pneumonia Diagnostic - Global Market Outlook (2016-2022)

Pneumonia Diagnostic - Global Market Outlook (2016-2022)

  • Published: March 2017
  • ID: SMRC16378

According to Stratistics MRC, the global Pneumonia Diagnostic market is accounted for $xx million in 2016 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2016 to 2022. Factors such as developing innovative technologies and products, increasing patient awareness and improving productivity of diagnosing pneumonia are boosting the market growth. Advent of new drugs and advance treatment facilitates are going to provide new market opportunities to emerge. However, there is no particular treatment available to detect the pneumonia as its symptoms coincide with diseases like bronchitis, common cold and asthma which are restraining the market growth.

Chest X-ray and CT scan are generally recommended for the diagnosis of pneumonia diagnostics. North America is the largest market due to increasing resistance to multi drugs by microorganisms and increasing geriatric population. Asia Pacific is anticipated to be the fastest growing market owing to prevalence of disease in several countries including India, Japan and Bangladesh. Additionally, high awareness and disposable income are potential growth factors.

Some of the key players in global Pneumonia Diagnostic market are Abbott, Affymetrix, Beckman Coulter Inc, Becton Dickinson, BioMerieux, Bio-Rad, Cepheid, Diamedix, Elitech Group, Qiagen, Siemens, Thermo Fisher Scientific, GlaxoSmithCline and Merck & Co. 

Treatments Covered:
• Vaccines
o PCV13
o PPV23
• Antibiotics
o Amoxicillin
o Cephalosporin
o Penicillin
o Tetracycline
o Vancomycin
o Fluoroquinolones
 
Tests Covered:
• Blood Test
• Bronchoscopy
• Chest X ray
• Chest Computed Tomography (CT) Scan
• Pulse Oximetry
• Pleural Fluid Culture
• Sputum Test

End Users Covered:
• Clinics
• Diagnostic Centres
• Hospitals
• Commercial/Private Labs
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific      
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary  
    
2 Preface 
  
 2.1 Abstract  
 2.2 Stake Holders 
 2.3 Research Scope 
 2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
 2.5 Research Sources 
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions
    
3 Market Trend Analysis 
 3.1 Introduction 
 3.2 Drivers  
 3.3 Restraints 
 3.4 Opportunities 
 3.5 Threats  
 3.6 End User Analysis 
 3.7 Emerging Markets 
 3.8 Futuristic Market Scenario
    
4 Porters Five Force Analysis 
 4.1 Bargaining power of suppliers
 4.2 Bargaining power of buyers
 4.3 Threat of substitutes
 4.4 Threat of new entrants
 4.5 Competitive rivalry 
    
5 Global Pneumonia Diagnostic Market, By Treatment
 5.1 Introduction 
 5.2 Vaccines  
  5.2.1 PCV13 
  5.2.2 PPV23 
 5.3 Antibiotics 
  5.3.1 Amoxicillin
  5.3.2 Cephalosporin
  5.3.3 Penicillin 
  5.3.4 Tetracycline
  5.3.5 Vancomycin 
  5.3.6 Fluoroquinolones
    
6 Global Pneumonia Diagnostic Market, By Test
 6.1 Introduction 
 6.2 Blood Test 
 6.3 Bronchoscopy 
 6.4 Chest X ray 
 6.5 Chest Computed Tomography (CT) Scan
 6.6 Pulse Oximetry 
 6.7 Pleural Fluid Culture
 6.8 Sputum Test 
    
7 Global Pneumonia Diagnostic Market, By End User
 7.1 Introduction 
 7.2 Clinics  
 7.3 Diagnostic Centres 
 7.4 Hospitals  
 7.5 Commercial/Private Labs
 7.6 Other End Users 
    
8 Global Pneumonia Diagnostic Market, By Geography
 8.1 North America 
  8.1.1 US 
  8.1.2 Canada 
  8.1.3 Mexico 
 8.2 Europe  
  8.2.1 Germany 
  8.2.2 France 
  8.2.3 Italy 
  8.2.4 UK 
  8.2.5 Spain 
  8.2.6 Rest of Europe
 8.3 Asia Pacific 
  8.3.1 Japan 
  8.3.2 China 
  8.3.3 India 
  8.3.4 Australia 
  8.3.5 New Zealand
  8.3.6 Rest of Asia Pacific
 8.4 Rest of the World 
  8.4.1 Middle East
  8.4.2 Brazil 
  8.4.3 Argentina
  8.4.4 South Africa
  8.4.5 Egypt 
    
9 Key Developments  
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
 9.2 Acquisitions & Mergers
 9.3 New Product Launch
 9.4 Expansions 
 9.5 Other Key Strategies
    
10 Company Profiling  
 10.1 Abbott  
 10.2 Affymetrix 
 10.3 Beckman Coulter Inc
 10.4 Becton Dickinson 
 10.5 bioMerieux 
 10.6 Bio-Rad  
 10.7 Cepheid  
 10.8 Diamedix  
 10.9 Elitech Group 
 10.10 Qiagen  
 10.11 Siemens  
 10.12 Thermo Fisher Scientific
 10.13 GlaxoSmithCline 
 10.14 Merck & Co 


List of Tables
1 Global Pneumonia Diagnostic Market Outlook, By Region (2014-2022) ($MN)
2 Global Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
3 Global Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
4 Global Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
5 Global Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
6 Global Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
7 Global Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
8 Global Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
9 Global Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
10 Global Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
11 Global Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
12 Global Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
13 Global Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
14 Global Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
15 Global Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
16 Global Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
17 Global Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
18 Global Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
19 Global Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
20 Global Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
21 Global Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
22 Global Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
23 Global Pneumonia Diagnostic Market Outlook, By Diagnostic Centres (2014-2022) ($MN)
24 Global Pneumonia Diagnostic Market Outlook, By Hospitals (2014-2022) ($MN)
25 Global Pneumonia Diagnostic Market Outlook, By Commercial/Private Labs (2014-2022) ($MN)
26 Global Pneumonia Diagnostic Market Outlook, By Other End Users (2014-2022) ($MN)
27 North America Pneumonia Diagnostic Market Outlook, By Country (2014-2022) ($MN)
28 North America Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
29 North America Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
30 North America Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
31 North America Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
32 North America Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
33 North America Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
34 North America Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
35 North America Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
36 North America Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
37 North America Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
38 North America Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
39 North America Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
40 North America Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
41 North America Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
42 North America Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
43 North America Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
44 North America Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
45 North America Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
46 North America Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
47 North America Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
48 North America Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
49 North America Pneumonia Diagnostic Market Outlook, By Diagnostic Centres (2014-2022) ($MN)
50 North America Pneumonia Diagnostic Market Outlook, By Hospitals (2014-2022) ($MN)
51 North America Pneumonia Diagnostic Market Outlook, By Commercial/Private Labs (2014-2022) ($MN)
52 North America Pneumonia Diagnostic Market Outlook, By Other End Users (2014-2022) ($MN)
53 Europe Pneumonia Diagnostic Market Outlook, By Country (2014-2022) ($MN)
54 Europe Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
55 Europe Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
56 Europe Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
57 Europe Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
58 Europe Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
59 Europe Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
60 Europe Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
61 Europe Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
62 Europe Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
63 Europe Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
64 Europe Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
65 Europe Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
66 Europe Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
67 Europe Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
68 Europe Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
69 Europe Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
70 Europe Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
71 Europe Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
72 Europe Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
73 Europe Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
74 Europe Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
75 Europe Pneumonia Diagnostic Market Outlook, By Diagnostic Centres (2014-2022) ($MN)
76 Europe Pneumonia Diagnostic Market Outlook, By Hospitals (2014-2022) ($MN)
77 Europe Pneumonia Diagnostic Market Outlook, By Commercial/Private Labs (2014-2022) ($MN)
78 Europe Pneumonia Diagnostic Market Outlook, By Other End Users (2014-2022) ($MN)
79 Asia Pacific Pneumonia Diagnostic Market Outlook, By Country (2014-2022) ($MN)
80 Asia Pacific Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
81 Asia Pacific Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
82 Asia Pacific Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
83 Asia Pacific Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
84 Asia Pacific Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
85 Asia Pacific Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
86 Asia Pacific Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
87 Asia Pacific Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
88 Asia Pacific Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
89 Asia Pacific Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
90 Asia Pacific Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
91 Asia Pacific Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
92 Asia Pacific Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
93 Asia Pacific Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
94 Asia Pacific Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
95 Asia Pacific Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
96 Asia Pacific Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
97 Asia Pacific Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
98 Asia Pacific Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
99 Asia Pacific Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
100 Asia Pacific Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
101 Asia Pacific Pneumonia Diagnostic Market Outlook, By Diagnostic Centres (2014-2022) ($MN)
102 Asia Pacific Pneumonia Diagnostic Market Outlook, By Hospitals (2014-2022) ($MN)
103 Asia Pacific Pneumonia Diagnostic Market Outlook, By Commercial/Private Labs (2014-2022) ($MN)
104 Asia Pacific Pneumonia Diagnostic Market Outlook, By Other End Users (2014-2022) ($MN)
105 RoW Pneumonia Diagnostic Market Outlook, By Country (2014-2022) ($MN)
106 RoW Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
107 RoW Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
108 RoW Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
109 RoW Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
110 RoW Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
111 RoW Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
112 RoW Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
113 RoW Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
114 RoW Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
115 RoW Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
116 RoW Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
117 RoW Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
118 RoW Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
119 RoW Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
120 RoW Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
121 RoW Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
122 RoW Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
123 RoW Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
124 RoW Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
125 RoW Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
126 RoW Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
127 RoW Pneumonia Diagnostic Market Outlook, By Diagnostic Centres (2014-2022) ($MN)
128 RoW Pneumonia Diagnostic Market Outlook, By Hospitals (2014-2022) ($MN)
129 RoW Pneumonia Diagnostic Market Outlook, By Commercial/Private Labs (2014-2022) ($MN)
130 RoW Pneumonia Diagnostic Market Outlook, By Other End Users (2014-2022) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials